DDInter856 DDInter314
Unfractionated heparin (UH) is a heterogenous preparation of anionic, sulfated glycosaminoglycan polymers with weights ranging from 3000 to 30,000 Da. It is a naturally occurring anticoagulant released from mast cells. It binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin (factor IIa) and factor Xa. UH is different from low molecular weight heparin (LMWH) in the following ways: the average molecular weight of LMWH is about 4.5 kDa whereas it is 15 kDa for UH; UH requires continuous infusions; activated partial prothrombin time (aPTT) monitoring is required when using UH; and UH has a higher risk of bleeding and higher risk of osteoporosis in long term use. Unfractionated hepar
A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.
Cefazolin {u} (Compound) resembles {v} (Compound) Cefotiam
Cefazolin {u} (Compound) resembles {v} (Compound) Cephaloglycin
Cefazolin {u} (Compound) binds {v} (Gene) ALB
Cefazolin {u} (Compound) is included by {v} (Pharmacologic Class) Cephalosporins
Cefazolin {u} (Compound) causes {v} (Side Effect) Erythema multiforme
Cefazolin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Neomycin
Cefazolin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Picosulfuric acid
Cefazolin (Compound) resembles Cefotiam (Compound)
Cefazolin (Compound) resembles Cephaloglycin (Compound)
Cefazolin (Compound) binds ALB (Gene)
Cefazolin (Compound) is included by Cephalosporins (Pharmacologic Class)
Cefazolin (Compound) causes Erythema multiforme (Side Effect)
Cefazolin may cause a moderate interaction that could exacerbate diseases when taken with Neomycin
Cefazolin may cause a moderate interaction that could exacerbate diseases when taken with Picosulfuric acid